Bristol-Myers Squibb Company announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2012. For the quarter, the company reported net sales of $4,191 million against $5,454 million a year ago. Earnings before income taxes were $513 million against $1,594 million a year ago. Net earnings attributable to BMS were $925 million or $0.56 per diluted share against $852 million or $0.50 per diluted share a year ago. Net earnings - non-GAAP attributable to unvested restricted shares were $777 million or $0.47 per diluted share against $906 million or $0.53 per diluted share a year ago.

For the full year, the company reported net sales of $17,621 million against $21,244 million a year ago. Earnings before income taxes were $2,340 million against $6,981 million a year ago. Net earnings attributable to BMS were $1,960 million or $1.17 per diluted share against $3,709 million or $2.18 per diluted share a year ago. Net earnings - non-GAAP attributable to unvested restricted shares were $3,363 million or $1.99 per diluted share against $3,913 million or $2.28 per diluted share a year ago.